Q1 2025 Earnings Call Transcript September 16, 2024 ImmunoPrecise Antibodies Ltd. misses on earnings expectations. Reported ...
IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (NASDAQ: IPA), an artificial intelligence-driven biotherapeutic ...
3d
ImmunoPrecise Antibodies (IPA – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst ...
ImmunoPrecise Antibodies (IPA) delivered earnings and revenue surprises of -22.22% and 22.44%, respectively, for the quarter ended July 2024. Do the numbers hold clues to what lies ahead for the stock ...
ImmunoPrecise Antibodies will report earnings from Q1.Analysts on Wall Street expect ImmunoPrecise Antibodies will release ...
Good morning, ladies and gentlemen, and thank you for joining us today for ImmunoPrecise Antibodies First Quarter Fiscal Year 2025 Earnings Call. We appreciate your time and interest in our company.
IMMUNOPRECISE ANTIBODIES LTD. (the “Company” or “IPA”) (NASDAQ: IPA), an artificial intelligence-driven biotherapeutic research and technology company, today reported financial results for ...
VICTORIA, British Columbia — IMMUNOPRECISE ANTIBODIES LTD. (the “Company” or “IPA”) (NASDAQ: IPA), an artificial intelligence-driven biotherapeutic research and technology company, today reported ...
VICTORIA, British Columbia--(BUSINESS WIRE)--IMMUNOPRECISE ANTIBODIES LTD. (the “Company” or “IPA”) (NASDAQ: IPA), an artificial intelligence-driven ...
IMMUNOPRECISE ANTIBODIES LTD. (the “Company” or “IPA”) (NASDAQ: IPA), an artificial intelligence-driven biotherapeutic research and technology company, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback